Waters Corporation Operating Income

Operating Income of WAT for past 10 years: annual, quarterly and twelve month trailing (TTM) including Operating Income growth rates and interactive chart. Operating income is the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation, and cost of goods sold (COGS). Operating income–also called income from operations–takes a company's gross income, which is equivalent to total revenue minus COGS, and subtracts all operating expenses. A business's operating expenses are costs incurred from normal operating activities and include items such as office supplies and utilities. Operating income is measured before interest and tax expenses and is a good gauge of a company's operational profitability.


Highlights and Quick Summary

  • Operating Income for the quarter ending December 30, 2020 was $264 Million (a 66.5% increase compared to previous quarter)
  • Year-over-year quarterly Operating Income increased by 286.22%
  • Annual Operating Income for 2020 was $645 Million (a -8.89% decrease from previous year)
  • Annual Operating Income for 2019 was $708 Million (a -4.23% decrease from previous year)
  • Annual Operating Income for 2018 was $740 Million (a 11.71% increase from previous year)
  • Twelve month Operating Income ending December 30, 2020 was $645 Million (a 4.42% increase compared to previous quarter)
  • Twelve month trailing Operating Income decreased by -1.54% year-over-year
Trailing Operating Income for the last four month:
30 Dec '20 29 Sep '20 29 Jun '20 30 Mar '20
$645 Million $618 Million $633 Million $656 Million
Visit stockrow.com/WAT for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Operating Income of Waters Corporation

Most recent Operating Incomeof WAT including historical data for past 10 years.

Interactive Chart of Operating Income of Waters Corporation

Waters Corporation Operating Income for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $263.71 $158.38 $155.11 $68.28 $645.49
2019 $236.42 $173.24 $177.65 $121.15 $708.46
2018 $244.53 $171.67 $179.19 $144.38 $739.77
2017 $230.57 $159.02 $153.88 $118.72 $662.2
2016 $209.04 $151.73 $151.61 $112.66 $625.04
2015 $181.31 $135.84 $130.32 $119.98 $567.45
2014 $172.04 $138.71 $118.4 $88.76 $517.91
2013 $176.18 $119.07 $112.69 $109.41 $517.34
2012 $159.41 $121.75 $120.12 $110.22 $511.49
2011 $164.87 $127.26 $120.57 $115.9 $528.6
2010 $148.18 $103.82 $105.58 $449.93

Business Profile of Waters Corporation

Sector: Healthcare
Industry: Diagnostics & Research
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company's offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company has a collaboration with Genovis AB to develop and market biopharmaceutical characterization workflows based on the its BioAccord LC-MS System, Andrew+ pipetting robot and Genovis SmartEnzymes. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.